Intra-arterial metabolic radiotherapy (using lipiodol labelled with iodine-131 or rhenium-188) is a therapeutic approach that can be used for the treatment of hepatocellular carcinomas (HCC). We propose a detailed description of the tumoral model using the N1-S1 cell line as well as a technique for intra-arterial injection of radiolabelled lipiodol in order to undertake preclinical studies necessary for the evaluation of a new molecule. We also report the principal technical pitfalls that were faced. The speed of injection of the tumoral cells is a key factor in the tumoral induction since slow injections lead to a tumoral induction rate of 36.3% compared with 76.6% (Po0.01) when using very slow injections. This parameter should thus be controlled carefully during the subcapsular injection of the tumoral cells. In addition, when injecting radiolabelled lipiodol, anaesthesia should not be performed with isoflurane since this leads to a reduction in tumoral uptake. Indeed, we found a 'tumour/ healthy liver' uptake ratio of only 2.170.7 with isoflurane as against 4.472.6 (Po0.05) when anaesthesia was carried out by intraperitoneal injection of ketamine. Lastly, we show that the tumour size has an influence on the tumoral uptake of radiolabelled lipiodol; therefore, this parameter must also be carefully controlled.
Summary
Intra-arterial metabolic radiotherapy (using lipiodol labelled with iodine-131 or rhenium-188) is a therapeutic approach that can be used for the treatment of hepatocellular carcinomas (HCC). We propose a detailed description of the tumoral model using the N1-S1 cell line as well as a technique for intra-arterial injection of radiolabelled lipiodol in order to undertake preclinical studies necessary for the evaluation of a new molecule. We also report the principal technical pitfalls that were faced. The speed of injection of the tumoral cells is a key factor in the tumoral induction since slow injections lead to a tumoral induction rate of 36.3% compared with 76.6% (Po0.01) when using very slow injections. This parameter should thus be controlled carefully during the subcapsular injection of the tumoral cells. In addition, when injecting radiolabelled lipiodol, anaesthesia should not be performed with isoflurane since this leads to a reduction in tumoral uptake. Indeed, we found a 'tumour/ healthy liver' uptake ratio of only 2.170.7 with isoflurane as against 4.472.6 (Po0.05) when anaesthesia was carried out by intraperitoneal injection of ketamine. Lastly, we show that the tumour size has an influence on the tumoral uptake of radiolabelled lipiodol; therefore, this parameter must also be carefully controlled.
Keywords Rat; hepatoma; intra-arterial injection; lipiodol Intra-arterial metabolic radiotherapy using lipiodol labelled with iodine-131 ( 131 I) (Garin & Bourguet 2004) or more recently with rhenium-188 ( 188 Re) (Wang et al. 1996a , Jeong et al. 2001 , Sundram et al. 2002 , Garin et al. 2004a ) is a therapeutic approach that can be applied for the treatment of hepatocellular carcinomas (HCC). The development of new molecules requires their evaluation on a tumoral model of hepatoma in the rat with injection via the hepatic artery. We have recently described a new type of lipiodol labelling with 188 Re, known as 188 Re-SSS lipiodol (Garin et al. 2004a,b) . We planned to carry out three preclinical studies on rats with HCC using this new product. The purpose of the first study was to assess the overall biodistribution of the 188 Re-SSS lipiodol (Garin et al. 2004b) . The second study was concerned with the tumoral biodistribution of 99m Tc-SSS lipiodol (Garin et al. 2004c ) emulsified with water in order to improve the tumoral targeting, a mechanism that has been previously described with 131 I-lipiodol (de Baere et al. 1999 et al. 1995 , De Jong et al. 2002 . In the present study, we propose a detailed description of the tumoral model and intraarterial injection technique that we used, as well as the principal technical pitfalls we had to face (the specific results of the various studies carried out are not presented here). Indeed, the literature only provides some brief descriptions of these two techniques (Wang et al. 1996a ,b, Hä feli et al. 1999 , Lin et al. 2000 , Jeong et al. 2001 ) .
Materials and methods
The animal experiments were performed on 222 female Sprague-Dawley rats weighing 241723 g, in compliance with the French regulations in force (law 0189.4 of 24 January 1990).
Conditions of husbandry
The rats used came from our breeding facility (animal department of the University of Angers, Angers, France, No. certification A 49 007 002). A microbiological status (bacteriological, parasitological and virological) is carried out every three months on the reproductive rats.
We allow for a period of acclimatization of one week before beginning an experiment. The rats are kept in cages of 38 Â 52 cm (six per cage) at a temperature of 20711C, with a relative humidity of 60%. Ventilation ensures a renewal of eight volumes of air per hour.
This animal department is equipped with 0.2 mm þ activated carbon filtration in the breeding area and simple particle filters in the other sectors. All of these parameters are connected to an alarm system functioning 24 h a day. Feed (feed for rats and mice, SAFE, Villemoisson-sur-Orge Barley, France) and water (tap water) are distributed ad libitum.
Cell line
The N1-S1 cell line from Novikoff hepatocarcinoma in rats (ATCC, Maryland, USA) was used for tumoral induction. It was established initially from a hepatocarcinoma induced in a male Sprague-Dawley rat, by ingestion of 4-dimethylaminoazobenzene (Novikoff 1957) . We cultivated this cell line in a DMEM culture medium (Dulbecco's modified Eagle's medium, Cambrex Biosciences, Verviers, France) supplemented with 20% horse serum (Cambrex Biosciences, Verviers, France), 5% fetal calf serum (Cambrex Biosciences, Verviers, France) and 1% antibiotics (Antibiotic Antimycotic Solution (100 Â ) stabilized, Sigma-Aldrich, Lyon, France). After three days, these cultures allowed us to obtain 25-30 Â 10 6 cells from an initial population of 0.8 Â 10 6 cells. The viability of each batch of cells was tested before their injection by testing with Trypan blue, which always yielded a result >90%.
Tumoral inoculation
Two parameters were varied: the type of anaesthesia used and the speed of injection of the cells.
Two types of anaesthesia were used:
Gas anaesthesia by isoflurane (Isoflurane Belamont, Belamont Laboratories, Boulogne Billancourt, France). The rats were placed in the induction cage unit (Minerve, Esternay, France) and induction was then obtained with an isoflurane/oxygen medical mixture (isoflurane 5%, oxygen medical 3 L/min) produced by an anaesthetic gas evaporator (Minerve, Esternay, France). The rats were then taken out of the induction room and anaesthesia was maintained using a mask, with an isoflurane/oxygen mixture (1-2% isoflurane, oxygen 3 L/ min).
Anaesthesia by intraperitoneal injection of 0.1 mL of xylazine (Rompun s 2%, Bayer, Puteau, France) and ketamine (Ketalar s 1000, Vetoquinol, Lure, France) spaced 10 mm apart.
Two speeds were applied for injecting the cells: slow (5-10 s) or very slow (30-40 s).
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Procedure of injection of the tumoral cells After anaesthesia, a 1.5 to 2 cm long subxiphoidian laparotomy was carried out, and the left hepatic lobe was exteriorized on a sterile compress. Then, 6 Â 10 6 cells in 0.15 mL DMEM were injected with a 27 G1/ 2 needle (MicrolanceTM 3, BD, New Jersey, USA) under the hepatic capsule so a pale whitish colouring (Figure 1 ) could be seen to diffuse as a layer from the periphery of the injection point to the hepatic margin. A gentle compression was then applied for 15 s with absorbent gauze composed of cotton and polyamide (B Braun, Boulogne, France) so as to avoid bleeding and reflux of the cells. The incision was closed up by two planes.
Intra-arterial injection of radiolabelled lipiodol (Figure 2)
The tumoral growth was checked 14 days later by a laparotomy (Figure 3 ). The operation was continued under a binocular magnifying glass. The first duodenal loop was then located and moved downward to expose the hepatic hilus. The gastroduodenal artery was located and carefully dissected until identification of the coeliac artery and the hepatic artery. The distal part of the gastroduodenal artery was ligatured, and a thread placed around the coeliac artery to stop arterial flow temporarily. The gastroduodenal artery was punctured upstream of the distal ligature using a 27 G butterfly needle (Microperfusor Valu-Set TM , BD, New Jersey, USA), blunted beforehand in order to avoid transpiercing the artery. The use of a blunted catheter is useful because of the occasionally irregular respiratory movements that can be responsible for large displacements of the liver. These can lead to an arterial lesion (this case occurred once at the beginning of an experiment using a non-blunted catheter).
The artery was ligatured onto the needle of the microperfusor in order to avoid any reflux during the injection. Injection of 6 Â 10 6 cells in 0.1 mL DMEM using a 27 G1/2 needle under the hepatic capsule, performed in such a way that a pale whitish colouring can be to seen to appear (5), emplacement of the catheter and ligature of the gastroduodenal artery on this catheter (4), loosening of the thread around the hepatic artery, injection of around the hepatic artery was loosened but left in place (which allowed better control, particularly in the case of haemorrhage or a need for repositioning). The correct positioning of the catheter was checked by injecting 0.1 mL of physiological salt solution. If the catheter was badly positioned (false channel, leakage), it was withdrawn and a new attempt at positioning could be made via the same incision. A new incision, upstream of the first, was sometimes necessary. Then, 0.1 mL of radiolabelled lipiodol was slowly injected (Figure 4) .
The microperfusor was rinsed with 0.1 mL physiological salt solution, and then the proximal part of the gastroduodenal artery (upstream of the puncture point) was tied off. The thread around the coeliac artery was withdrawn in order to restore hepatic arterial flow. The incision was closed up again by the two planes.
Studies of biodistribution
The rats were killed (anaesthesia by isoflurane, then CO 2 inhalation) from one to 48 h after injection of 188 Re-SSS lipiodol (for the overall biodistribution) or emulsified 99m Tc-SSS lipiodol (for the tumoral biodistribution). Various organs were then removed, their total activity being measured on a well counter (Auto gamma cobra II, Packard, Boston, USA) and expressed as a percentage of the activity injected per gram of tissue (% IA/g). The tumour/non-tumoral liver uptake ratio is defined as the percentage injected activity per gram of tumour (% IA/g) divided by the percentage injected activity per gram of healthy liver (% IA/g).
We performed a biodistribution study of 188 Re-SSS lipiodol on seven rats with HCC, carrying out injection of the 188 Re-SSS lipiodol under anaesthesia by isoflurane. We also studied the biodistribution of 188 Re-SSS lipiodol in nine rats with HCC, infusing the 188 Re-SSS lipiodol under anaesthesia with an intraperitoneal injection of xylazine and ketamine.
A study of the tumoral biodistribution of emulsified 99m Tc-SSS lipiodol was carried out using different emulsions on 46 rats, two control groups of five rats, and eight groups of three to five rats.
Study of survival
This study was undertaken on four groups of 14 rats: a control group received 0. I-lipiodol. After the treatment, the rats were put back in cages until their spontaneous death in order to study survival.
Non-tumoral rats
The rats failing to accept the tumoral graft were sacrificed by CO 2 inhalation at the end Coeliac artery Figure 4 Injection of 188 Re -SSS lipiodol via the hepatic artery of the rat. The catheter is in place in the gastroduodenal artery, which is ligatured above, while injection is carried out of an emulsion of 99m Tc-SSS lipiodol and water of the procedure for checking tumoral growth. Table 1 reports the distribution of the rats presenting with a tumour and their outcomes in the various studies.
Statistics
Statistical studies were carried out with a SAS software application. The tumoral induction rates were compared according to the anaesthetic used by means of a w 2 test. The tumour/non-tumoral liver uptake ratios and tumour weights were analysed using the Kruskal-Wallis non-parametric test for comparing means. A value of 0.05 was adopted as the statistical threshold of significance.
Results and discussion
Out of the 222 injections of tumoral cells carried out, we obtained tumoral induction in 131 rats, i.e. in 59.1% of cases. For the 62 tumours that were weighed (biodistribution studies), the average weight was 2.4372.61 g (min ¼ 0.45 g, max ¼ 8.29 g). In 124 cases, the tumour was localized in the liver, while in seven cases (5.6%), we observed a peritoneal carcinosis with haemorrhagic ascites.
In the first 77 rats, we carried out slow injections of tumoral cells (5-10 s) during the operation under anaesthesia by isoflurane. We obtained tumours in 28 rats, corresponding to a tumoral induction rate of only 36.3%.
We then considered the possible influence of the type of anaesthetic used on the tumoral induction rate, given that isoflurane has a marked vasodilator action. We therefore carried out 21 slow injections of tumoral cells during operations under anaesthesia with intraperitoneal injection of xylazine and ketamine. This procedure gave rise to tumours in five rats (tumoral induction rate of 23.8%).
We then investigated the possibility that speed of injection might influence the tumoral induction rate, and carried out the 124 remaining injections of tumoral cells very slowly (30-40 s) during the operations under anaesthesia with intraperitoneal injection of xylazine and ketamine. We obtained tumours in 98 rats, i.e. a tumoral induction rate of 76.6%, which is significantly higher than in the case of slow injections (Po0.001). Therefore, these results show unequivocally that the speed of injection of the tumoral cells has a major influence on the tumoral induction rate, and the injection speed must be kept very slow to enhance induction. Those results could be explained by a lower risk of bleeding and cells loosening, with slower injections, and by lesser damages on tumoral cells or on the healthy hepatic tissue receiving the tumoral cells. This point has not been clearly addressed in previously published work, where the authors simply mention in certain cases that the tumoral cells were injected slowly and do not provide results about the tumoral induction rate (Wang et al. 1996a ,b, Hä feli et al. 1999 , Lin et al. 2000 , Jeong et al. 2001 . Otherwise, with the aim of adopting the least aggressive treatment possible towards the animals, we wanted to favour the use of anaesthesia with isoflurane instead of the more commonly used intraperitoneal injection of xylazine and ketamine (Wang et al. 1996a ,b, Lin et al. 2000 .
Indeed, the use of isoflurane allows a fast and painless anaesthesia of the animals, followed by a rapid recovery (a few minutes), thus leading to an optimal adaptation of the anaesthesia to the duration of the operation. On the other hand, anaesthesia by intraperitoneal injection of xylazine and ketamine is more stressful for the animals, being longer to obtain and involving a longer recovery time. It is also more difficult to adapt the duration of anaesthesia precisely to the duration of the operation. In addition, with this type of anaesthesia, we recorded three deaths out of 340 anaesthesias.
During the first study on biodistribution of 188 Re-SSS lipiodol carried out on seven rats with HCC, the injection of 188 Re-SSS lipiodol was performed under anaesthesia by isoflurane, and we obtained a tumour/nontumoral liver uptake ratio of only 2.170.7%.
These results are lower than the previously published values obtained with 188 Re-labelled lipiodol: 3.0370.42 to 6.4570.87 in the study of Wang et al. (1996a) , and 6.2574.46 to 11.7710.7 in the study of Jeong et al. (2001) . As a consequence, we considered the possibility that isoflurane might have an influence on the intrahepatic biodistribution of 188 Re-SSS lipiodol. Indeed, it has been shown that the use of vasoconstrictor agents leads to an increase in the tumoral uptake of radiolabelled microspheres within the HCC (Burton et al. 1985 , Sasaki et al. 1985 , Burton et al. 1988 ). This appears to take place through a preferential action on the healthy hepatic vessels and a less marked action on the immature tumoral neo-vessels, involving a redistribution of arterial flow towards the tumours. We propose here the possibility of a opposite phenomenon associated with the use of isoflurane, a powerful vasodilator that could be responsible for a redistribution of hepatic arterial flow towards the healthy liver to the detriment of the tumour. In our study of the biodistribution of 188 Re-SSS lipiodol in nine rats with HCC, the 188 Re-SSS lipiodol was injected under anaesthesia with intraperitoneal injection of xylazine and ketamine. We found a significantly higher tumour/non-tumoral liver uptake ratio (4.472.6 as against only 2.170.7, P ¼ 0.05), thus supporting the hypothesis of a redistribution of hepatic arterial flow towards the healthy liver due to the use of isoflurane. We did not use postoperative analgesics routinely at the time of this study. Our institution's practice at the time of publication is now that such use of analgesics is routine.
Lastly, while carrying out the study of tumoral biodistribution of emulsified 99m Tc-SSS lipiodol, we investigated two control groups that received pure 99m Tc-SSS lipiodol. In the first group, the rats had large-sized tumours, 6.3772.09 g, as against 1.8871.04 g in the second control group (Po0.01). In the first group, the tumour/nontumoral liver uptake ratio was significantly lower than in the second group, i.e. 1.39 versus 2.48 (P ¼ 0.04). These results show that the uptake of the radiolabelled lipiodol is related to the tumoral weight. Thus, while carrying out studies with this tumoral model, it is necessary to obtain homogeneous groups in terms of tumour Laboratory Animals (2005) 39 size. In humans, the size of the HCC is reported to have an influence on the uptake of 131 I-lipiodol for tumours larger than 5 or even 10 cm in diameter (Raoul et al. 1993 ), but is not described for tumours of small size (0.5-3 cm in diameter) found in the rat.
Conclusion
We propose here a detailed description of a technique for the injection of N1-S1 cells under the hepatic capsule to induce hepatoma in the rat, as well as the injection of radiolabelled lipiodol via the hepatic artery. The principal technical problems that we encountered were (i) the excessively fast injection of tumoral cells causing a low rate of tumoral induction, (ii) the use of isoflurane during intra-arterial injection of radiolabelled lipiodol leading to a significant lowering of tumoral uptake, and (iii) an inversely proportional relation between tumoral uptake and tumour size.
During use of this tumoral model and the intra-arterial injection of radiolabelled lipiodol, it is thus necessary to take care to inject the tumoral cells very slowly (in more than 30 s). Moreover, the use of isoflurane should be proscribed and the homogeneity of tumour size should be carefully controlled in the various studied groups.
